Session Details
[1S10a]Maintenance and disruption of homeostasis by ion channels: Structural, functional, and pharmacological analyses
Mon. Mar 17, 2025 1:40 PM - 3:30 PM JST
Mon. Mar 17, 2025 4:40 AM - 6:30 AM UTC
Mon. Mar 17, 2025 4:40 AM - 6:30 AM UTC
Room 10
Oranizers :Hiroko Izumi-Nakaseko (Department of Pharmacology, Faculty of Medicine, Toho University) and Tomoe Y. Nakamura-Nishitani (Department of Pharmacology, Faculty of Medicine, Wakayama Medical University)
Responsiveness to diverse endogenous and exogenous stimuli is essential to maintain homeostasis in the body, and ion channels play a pivotal role in this process. For example, they generate and coordinate fundamental responses including nerve excitability, muscle contraction and its beating rhythms, and secretion; and their dysfunction can be the cause of many diseases. However, the current understanding of ion channels has been still limited in the area of the necessary and sufficient conditions for development of ion channel-mediated diseases, the effects of post-translational modifications, and specific drugs suitable for therapy. In this symposium, we will present the latest findings on novel physiological functions and regulatory mechanisms of some ion channels, as well as their pathological roles and therapeutic strategies in the cases of their structural and/or functional failure. Specifically, we will address ion channel modifications involved in synchrony of myocardial contraction and excitation conduction, atherosclerosis and osteogenesis, and comprehensive drug discovery for these channels. Integrated understanding through their anatomical, physiological, and pharmacological analyses could provide novel prophylactic and therapeutic strategies for the diseases.
[1S10a-1]Piezo1 and Piezo2 channels in allergic asthma-induced bone loss
○Mizuho A Kido1, Weiqi Gao1, Takeshi Sawada1, Ailin Cao1, Reiko Yoshimoto1, Yu Yamaguchi2, Takaichi Fukuda4, Yasuyoshi Ohsaki1, Reona Aijima3, Tomoko Kadowaki5, Takayuki Tsukuba2 (1.Department of Anatomy and Physiology, Faculty of Medicine, Saga University, 2.Department of Dental Pharmacology, Graduate School of Biomedical Sciences, Nagasaki University, 3.Department of Oral & Maxillofacial Surgery, Faculty of Medicine, Saga University, 4.Department of Anatomy and Neurobiology, Graduate School of Medical Sciences, Kumamoto University, 5.Department of Frontier Life Science, Graduate School of Biomedical Sciences, Nagasaki University)
[[OD]1S10a-2]The Importance of C-terminal Tyrosine Phosphorylation of CaV1.2 in Pathological Vascular Remodeling
○Takuro Tomita Numaga-Tomita (Shinshu University School of medicine, Department of Molecular Pharmacology)
[1S10a-3]Identification of the specific components of natural products targeting GIRK channel and the modulatory mechanism of drug action
○I-Shan Chen, Tomoe Y. Nakamura-Nishitani (Wakayama Medical University)
[[OD]1S10a-4]Mechanisms and treatments for disorders caused by abnormal activation of the type 2 ryanodine receptor (RyR2)
○Nagomi Kurebayashi (Dept Pharmacol, Juntendo Univ Fac Med)
[1S10a-5]Relationship between the ion channel blocking properties of drugs and the formation of trigger and substrate required for ventricular arrhythmias
○Hiroko Izumi-Nakaseko1, Yuko Sekino2,3, Ryuichi Kambayashi1, Ai Goto1, Yoshinori Takei1,4, Yukiko Himeno5, Ayako Matsumoto6, Yoshinobu Nagasawa7, Atsuhiko T Naito8, Yasunari Kanda9, Atsushi Sugiyama1,4 (1.Dept. Pharmacol., Facl. Med., Toho University, 2.Grad. Sch. Agric. Life Sci., Univ. Tokyo, 3.Inst. Drug Discovery Innov., 4.YOKOYAMA Kazuya Cancer Res. Inst., 5.Dept. Bioinformatics, Coll. Life Sci., Ritsumeikan Univ., 6.Lab. Biochem., Dept. Biol., Facl. Sci., Toho Univ., 7.Dept. Pharmacology and Therapeutics, Facl. Pharmaceutical Sci., Toho Univ., 8.Dept. Physiol., Div. Cell Physiol., Grad. Sch. Med., Toho Univ., 9.Div. Pharmacol., NIHS)